Company / Cash per Share
Edwards Lifesciences Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$5.06
FY2025
5-year range
$1.26 / $5.07
FY2021-FY2025
Trend
-0.1%
vs FY2024
Sector context
#47 of 146
Health Care
What the data says
At $5.06, Edwards Lifesciences's cash per share ranks #47 of 146 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $1.26 in FY2022 to $5.64 in FY2019.
Based on SEC 10-K filings.
5.06 in FY2025 with a 5-year CAGR of +21.7%.
Improved from $1.88 to $5.06 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +58.8%
- 5-Year CAGR
- +21.7%
- 10-Year CAGR
- -
Sector benchmark
#47 of 146 in Health CareTop 32% of 146This company $5.06 Sector average $27.73
▼
-81.8% below sector average
Key checks
Key Insights
- In FY2025, cash per share decreased 0.1% year-over-year.
- Ranks #47 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2019.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 3.16 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $5.06 | -0.1% |
| FY2024 | $5.07 | +169.4% |
| FY2023 | $1.88 | +48.8% |
| FY2022 | $1.26 | -8.6% |
| FY2021 | $1.38 | -27.1% |
| FY2020 | $1.90 | -66.4% |
| FY2019 | $5.64 | +64.0% |
| FY2018 | $3.44 | -11.1% |
| FY2017 | $3.87 | -12.0% |
| FY2016 | $4.40 | -34.0% |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026